Even Bigger Venture Bucks For Obesity Therapies As Metsera Sells For Up To $10B

Metsera, a company focused on obesity therapies, has been sold for up to $10 billion. This sale is part of a larger trend where several companies in the obesity and weight management sector have raised significant venture funding in recent years. The increasing investment in this industry highlights the growing concern over obesity and the demand for effective weight management solutions.